Susannah Gray

Professional at Royalty Pharma Plc

Susannah Gray

Susannah Gray

Professional at Royalty Pharma Plc

Biography

Susannah Gray is on the board of The German Marshall Fund of United States and 9 other companies. In the past she occupied the position of Executive Vice President-Finance & Strategy at RP Management LLC, Managing Director at Merrill Lynch & Co., Inc. and Analyst at CIBC World Markets Corp. (Old). She received an undergraduate degree from Wesleyan University and an MBA from Columbia Business School.

Overview
Career Highlights

RP Management LLC

RelSci Relationships

1962

Number of Boards

13

Birthday

1961

Age

60

Contact Data
Trying to get in touch with Susannah Gray? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Susannah Gray likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Apria Healthcare Group LLC

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Morphic Holding, Inc.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Royalty Pharma Plc

Relationship likelihood: Strong

Executive Vice President, Investments & General Counsel at Royalty Pharma Plc

Relationship likelihood: Strong

Chief Executive Officer at Maravai Lifesciences Holdings, Inc.

Relationship likelihood: Strong

Executive Vice President & Head-Research & Investments at RP Management LLC

Relationship likelihood: Strong

Co-Founder at Moderna, Inc.

Relationship likelihood: Strong

Senior Vice President-Finance at RP Management LLC

Relationship likelihood: Strong

Chief Accounting Officer at RP Management LLC

Relationship likelihood: Strong

Chief Financial Officer & Executive Vice President at Royalty Pharma Plc

Relationship likelihood: Strong

Paths to Susannah Gray
Potential Connections via
Relationship Science
You
Susannah Gray
Professional at Royalty Pharma Plc
Education

Wesleyan University is known for the excellence of its academic and co-curricular programs. About 2,900 undergraduates—and some 200 graduate students—from around the world pursue their classroom studies, research projects, and co-curricular interests in ways that are demanding and intensely rewarding. Here, on a beautiful campus overlooking the Connecticut River, students learn to do productive and innovative work that makes a positive difference in the world—that’s what Wesleyan is about.

Columbia Business School (CBS) is the business school of Columbia University in Manhattan, New York City. It was established in 1916 to provide business training and professional preparation for undergraduate and graduate Columbia University students. It is one of six Ivy League business schools and its admission process is among the most selective of top business schools.

Career History
Executive Vice President & Chief Financial Officer
2005 - 2019

RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Managing Director
1999 - Prior

Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC.

Professional
Current

Royalty Pharma Plc provides drug development services. The firm operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Political Donations
$2,500
2013

Senator from Ohio

$2,500
2013

Senator from Delaware

$2,500
2013

Senator from Michigan

Transactions
Details Hidden

Apria, Inc. issued USD Common Stock

Details Hidden

Royalty Pharma Plc issued USD Ordinary Shares

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Susannah Gray. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Susannah Gray's profile does not indicate a business or promotional relationship of any kind between RelSci and Susannah Gray.